Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a correction. Please see:

Correction: Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells - September 01, 2022

Review

Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells

Online download statistics by month:

Online download statistics by month: May 2022 to March 2024

	Abstract	Full	Pdf
May 2022	539	559	239
Jun 2022	761	794	244
Jul 2022	747	793	249
Aug 2022	922	934	208
Sep 2022	946	994	242
Oct 2022	929	959	224
Nov 2022	919	932	234
Dec 2022	558	578	157
Jan 2023	535	547	158
Feb 2023	517	535	167
Mar 2023	559	573	147
Apr 2023	679	710	170
May 2023	734	748	140
Jun 2023	645	652	113
Jul 2023	631	640	127
Aug 2023	513	521	125
Sep 2023	523	533	96
Oct 2023	628	637	103
Nov 2023	582	596	131
Dec 2023	592	596	103
Jan 2024	365	367	65
Feb 2024	352	354	60
Mar 2024	563	566	100
Total	14739	15118	3602